Antiproteinuric Effects of Liraglutide Treatment

NCT02545738 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Kidney Disease

Interventions

DRUG: Liraglutide
DRUG: placebo

Sponsor

Steno Diabetes Center Copenhagen

Collaborators

[object Object]